tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XOMA Stock Latest News

Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
RatingsStrategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
6d ago
XOMA
Generation Bio price target lowered to $5.50 from $7 at Wedbush
PremiumThe Fly
Generation Bio price target lowered to $5.50 from $7 at Wedbush
6d ago
GBIO
MRNA
Generation Bio downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Generation Bio downgraded to Hold from Buy at Jefferies
7d ago
GBIO
XOMA
Xoma to acquire Generation Bio for $4.2913 per share
PremiumThe Fly
Xoma to acquire Generation Bio for $4.2913 per share
7d ago
GBIO
XOMA
Xoma to acquire Generation Bio for $4.2913 per share
PremiumThe Fly
Xoma to acquire Generation Bio for $4.2913 per share
7d ago
GBIO
XOMA
Buy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
PremiumRatingsBuy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
10d ago
XOMA
Xoma price target lowered to $97 from $104 at H.C. Wainwright
Premium
The Fly
Xoma price target lowered to $97 from $104 at H.C. Wainwright
11d ago
XOMA
Xoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
Premium
Ratings
Xoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
11d ago
XOMA
Xoma price target lowered to $45 from $58 at Leerink
PremiumThe Fly
Xoma price target lowered to $45 from $58 at Leerink
11d ago
RZLT
XOMA
Xoma falls 21% after partner Rezolute announces trial failure
PremiumThe Fly
Xoma falls 21% after partner Rezolute announces trial failure
11d ago
RZLT
XOMA
Xoma price target lowered to $66 from $76 at Lucid Capital
PremiumThe Fly
Xoma price target lowered to $66 from $76 at Lucid Capital
11d ago
XOMA
Xoma initiated with a Buy at Lucid Capital
PremiumThe Fly
Xoma initiated with a Buy at Lucid Capital
13d ago
XOMA
Xoma Completes Acquisition of Mural Oncology
PremiumCompany AnnouncementsXoma Completes Acquisition of Mural Oncology
17d ago
8K
XOMA
Xoma announces closing of transaction to acquire Mural Oncology
Premium
The Fly
Xoma announces closing of transaction to acquire Mural Oncology
17d ago
MURA
XOMA
Mural Oncology announces effectiveness of scheme of arrangement
Premium
The Fly
Mural Oncology announces effectiveness of scheme of arrangement
17d ago
MURA
XOMA
Mural Oncology announces final cash consideration payable on acquisition close
PremiumThe Fly
Mural Oncology announces final cash consideration payable on acquisition close
26d ago
MURA
XOMA
XOMA Completes Acquisition of LAVA Therapeutics
PremiumCompany Announcements
XOMA Completes Acquisition of LAVA Therapeutics
1M ago
8K
XOMA
Xoma announces closing of transactions to acquire Lava Therapeutics
PremiumThe Fly
Xoma announces closing of transactions to acquire Lava Therapeutics
1M ago
LVTX
XOMA
Lava Therapeutics announces intent to delist from Nasdaq
PremiumThe Fly
Lava Therapeutics announces intent to delist from Nasdaq
1M ago
LVTX
XOMA
Xoma Corp. Reports Strong Turnaround in Q3 Earnings
PremiumCompany AnnouncementsXoma Corp. Reports Strong Turnaround in Q3 Earnings
1M ago
XOMA
Xoma reports Q3 EPS 70c, consensus (4c)
Premium
The Fly
Xoma reports Q3 EPS 70c, consensus (4c)
1M ago
XOMA
XOMA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
XOMA Earnings this Week: How Will it Perform?
2M ago
XOMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >